203 related articles for article (PubMed ID: 35740845)
1. VEGF Pathway Gene Expression Profile of Proliferating versus Involuting Infantile Hemangiomas: Preliminary Evidence and Review of the Literature.
Heredea RE; Melnic E; Cirligeriu LE; Berzava PL; Stănciulescu MC; Popoiu CM; Cimpean AM
Children (Basel); 2022 Jun; 9(6):. PubMed ID: 35740845
[No Abstract] [Full Text] [Related]
2. Presence of estrogen and progesterone receptors in proliferating and involuting infantile hemangiomas.
Johnson A; Zhang H; Gonzalez SR; Lee M; Wei T; Richter G
J Plast Reconstr Aesthet Surg; 2021 Nov; 74(11):3061-3065. PubMed ID: 34011473
[TBL] [Abstract][Full Text] [Related]
3. Conventional ultrasonography and elastography for the diagnosis of congenital and infantile hemangiomas.
Gong X; Hua C; Xiong P; Li J; Ding A; Lin X; Wang L
J Dermatol; 2020 May; 47(5):527-533. PubMed ID: 32096237
[TBL] [Abstract][Full Text] [Related]
4. Biomolecular markers and involution of hemangiomas.
Frischer JS; Huang J; Serur A; Kadenhe A; Yamashiro DJ; Kandel JJ
J Pediatr Surg; 2004 Mar; 39(3):400-4. PubMed ID: 15017560
[TBL] [Abstract][Full Text] [Related]
5. Identification of signaling systems in proliferating and involuting phase infantile hemangiomas by genome-wide transcriptional profiling.
Calicchio ML; Collins T; Kozakewich HP
Am J Pathol; 2009 May; 174(5):1638-49. PubMed ID: 19349369
[TBL] [Abstract][Full Text] [Related]
6. [Indentification of differentially expressed genes in proliferating and involuting hemangiomas by cDAN microarray analysis of gene-expression profiles].
Zhang L; Wang W; Qi ZL; Dong JS; Song HD; Yang JS; Lin XX
Zhonghua Zheng Xing Wai Ke Za Zhi; 2003 Nov; 19(6):452-5. PubMed ID: 15004904
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the role of serum vascular endothelial growth factor and urinary basic fibroblast growth factor in differential diagnosis of vascular anomalies].
Zhang L; Chen Q; Li D; Li XW; Wang HG; Li GZ
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1092-5. PubMed ID: 21609589
[TBL] [Abstract][Full Text] [Related]
8. [The expression of CEACAM-1 and CXCL-14 in infantile hemangioma].
Xu GQ; Lü RR; Huo R; Guo X
Zhonghua Zheng Xing Wai Ke Za Zhi; 2010 May; 26(3):195-8. PubMed ID: 20737948
[TBL] [Abstract][Full Text] [Related]
9. Local serum levels of vascular endothelial growth factor in infantile hemangioma: intriguing mechanism of endothelial growth.
Przewratil P; Sitkiewicz A; Andrzejewska E
Cytokine; 2010 Feb; 49(2):141-7. PubMed ID: 20015661
[TBL] [Abstract][Full Text] [Related]
10. Infantile hemangioma is a proliferation of LYVE-1-negative blood endothelial cells without lymphatic competence.
Nguyen VA; Kutzner H; Fürhapter C; Tzankov A; Sepp N
Mod Pathol; 2006 Feb; 19(2):291-8. PubMed ID: 16424896
[TBL] [Abstract][Full Text] [Related]
11. Expression and association of VEGF-Notch pathways in infantile hemangiomas.
Li S; Xu G; Gao F; Bi J; Huo R
Exp Ther Med; 2017 Oct; 14(4):3737-3743. PubMed ID: 29042972
[TBL] [Abstract][Full Text] [Related]
12. A study of serum vascular endothelial growth factor in infantile hemangiomas.
Paria S; Mendiratta V; Chander R; Jain A; Mittal S
Indian J Dermatol Venereol Leprol; 2019; 85(1):65-68. PubMed ID: 29469063
[TBL] [Abstract][Full Text] [Related]
13. [Expression of bcl-2 and survivin gene products in different stages of vessel differentiation in hemangiomas].
Tan HS; Qin XJ; Wang XK
Shanghai Kou Qiang Yi Xue; 2008 Apr; 17(2):204-7. PubMed ID: 18470430
[TBL] [Abstract][Full Text] [Related]
14. One Possible Mechanism of Pulsed Dye Laser Treatment on Infantile Hemangioma: Induction of Endothelial Apoptosis and Serum vascular endothelial growth factor (VEGF) Level Changes.
Cao Y; Wang F; Jia Q; Xu R; Dang W; Chen Q; Lin L; Wang Y
J Lasers Med Sci; 2014; 5(2):75-81. PubMed ID: 25653803
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis characteristics of infantile hemangioma and feasibility observation of transplantation model of human hemangioma on mice.
Fu Y; Yang ZG; Zhao LY
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1276-1280. PubMed ID: 28387902
[TBL] [Abstract][Full Text] [Related]
16. Congenital nonprogressive hemangioma: a distinct clinicopathologic entity unlike infantile hemangioma.
North PE; Waner M; James CA; Mizeracki A; Frieden IJ; Mihm MC
Arch Dermatol; 2001 Dec; 137(12):1607-20. PubMed ID: 11735711
[TBL] [Abstract][Full Text] [Related]
17. The pigment epithelium-derived factor (PEDF): an important potential therapeutic agent for infantile hemangioma.
Li M; Chen Y; Guo Z; Xie Y; Zhou Y; Jiang C; Chen X
Arch Dermatol Res; 2017 Apr; 309(3):169-178. PubMed ID: 28197761
[TBL] [Abstract][Full Text] [Related]
18. Partially involuting congenital hemangiomas: a report of 8 cases and review of the literature.
Nasseri E; Piram M; McCuaig CC; Kokta V; Dubois J; Powell J
J Am Acad Dermatol; 2014 Jan; 70(1):75-9. PubMed ID: 24176519
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous evolution patterns of focal congenital hepatic hemangiomas: a case series of 25 patients.
Rutten C; Ladarre D; Ackermann O; Gonzales E; Guettier C; Franchi-Abella S
Pediatr Radiol; 2022 May; 52(6):1048-1060. PubMed ID: 35229180
[TBL] [Abstract][Full Text] [Related]
20. KIAA1429 promotes infantile hemangioma regression by facilitating the stemness of hemangioma endothelial cells.
Wang L; Zou Y; Huang Z; Wang W; Li J; Bi J; Huo R
Cancer Sci; 2023 Apr; 114(4):1569-1581. PubMed ID: 36572002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
